Stocks · Health care · Pharmaceutical Preparations

ZEVRA THERAPEUTICS, INC.

ZVRA Clue Score60

United States Fiscal year ends December CIK 0001434647 Results filed 3 Nov 2026

Add to watchlist

What the insiders did Scheduled selling only

Individual transactions

Insider

Date

Role

Action

Price

Amount

Corey Michael Watton

10 Aug 2026

Director

Sold after exercise

12,300

$11.25

$138.38K

Joshua Schafer

30 Jan 2026

CCO

Sold after exercise

3,375

$8.83

$29.80K

Adrian W Quartel

30 Jan 2026

Chief Medical Officer

Sold after exercise

4,533

$8.83

$40.04K

Rahsaan Thompson

30 Jan 2026

Chief Legal & Compliance

Sold after exercise

4,080

$8.83

$36.01K

Timothy J. Sangiovanni

30 Jan 2026

SVP, Finance & Corp Controller

Sold after exercise

1,750

$8.82

$15.44K

Show all 15 transactions →

What was left out

Form 4 filings counted 24

Amendments (4/A) skipped 0

Filings about a different issuer 0

Unreadable filings 0

Joint filings 0

Sales on a Rule 10b5-1 plan 8

Sales straight out of an exercise 5

Sales at will 0

Transactions with no price 0

Shares from compensation/vesting 754,713

History held since 17 Apr 2015